The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Abstract
Drugs of abuse are very powerful reinforcers, and even in conditions of limited access (where the organism is not dependent) these drugs will motivate high rates of operant responding. This presumed hedonic property and the drugs' neuropharmacological specificity provide a means of studying the neuropharmacology and neuroanatomy of brain reward. Three major brain systems appear to be involved in drug reward--dopamine, opioid and GABA. Evidence suggests a midbrain-forebrain-extrapyramidal circuit with its focus in the nucleus accumbens. Data implicating dopamine and opioid systems in indirect sympathomimetic and opiate reward include critical elements in both the nucleus accumbens and ventral tegmental areas. Ethanol reward appears to depend on an interaction with the GABAA receptor complex but may also involve common elements such as dopamine and opioid peptides in this midbrain-forebrain-extrapyramidal circuit. These results suggest that brain reward systems have a multidetermined neuropharmacological basis that may involve some common neuroanatomical elements.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, there is extensive experimental evidence in animal contexts supporting a role for the mesolimbic reward pathway on appetitive and motivational behaviors [306,307].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [307]
In the citing paper
“The meso-limbic dopamine system that projects from the ventral tegmental area (VTA) to the nucleus accumbens has been implicated in the rewarding effects of drugs of abuse”
From Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) · cites this paper as Koob, 1992
Citations
Cites
Handbook of Psychopharmacology
Iversen, L. L., Iversen, S. D., & Snyder, S. H. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,756
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
From motivation to action: Functional interface between the limbic system and the motor system
MOGENSON, G., JONES, D., & YIM, C. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90018-0 · Cited by 2,331
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citationWise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
An opponent-process theory of motivation. I. Temporal dynamics of affect
Solomon, R. L., & Corbit, J. D. (1974) · Psychological Review · doi:10.1037/h0036128 · Cited by 1,704
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Fallon, J. H., & Moore, R. Y. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901800310 · Cited by 1,190
Mesocorticolimbic dopaminergic network: functional and regulatory roles
Moal, M. L., & Simon, H. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.155 · Cited by 1,108
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
Research works printed but not linked: 21
- Dahlström, 1964, Acta Physiol. Scand., 232, 1
- Weiss, F. et al.Ann. NY Acad. Sci. (in press).
- Pfeffer, 1985, Alcohol Drug Res., 6, 37
- Rassnick, S., Pulvirenti, L. and Koob, G. F. Psychopharmacology (in press).
- Samson, 1988, Alcohol. Clin. Exp. Res., 12, 581
- Imperato, 1986, J. Pharmacol. Exp. Ther., 239, 221
- Bodnar, 1990, Crit. Rev. Neurobiol., 6, 39
- West, 1989, Soc. Neurosri. Abstr., 15, 20.8
- Koob, 1984, J. Pharmacol. Exp. Ther., 229, 481
- Goldberg, 1971, J. Pharmacol. Exp. Ther., 176, 464
- Di Chiara, 1988, J. Pharmacol. Exp. Ther., 244, 1067
- Di Chiara, 1988, 85, 5274
- Shippenberg, T. S., Spanagel, R. and Herz, A.Ann. NY Acad. Sci. (in press).
- Givens, 1990, J. Pharmacol. Exp. Ther., 254, 528
- Sepinwall, 1978, Vol. 13, 345
- Koob, G. F. and Britton, K. T. in Pharmacology and Neuropharmacology (Vol. 2) Alcohol and Alcoholisms (Begleiter, H. and Kissin, B., eds), Oxford University Press (in press).
- Frye, 1982, J. Pharmacol. Exp. Ther., 223, 750
- Suzdak, 1986, 83, 4071
- Rassnick, S. et al.Ann. NY Acad. Sci. (in press).
- Deitrich, 1989, Pharmacol. Rev., 41, 489
- Pickens, 1981, J. Pharmacol. Exp. Ther., 216, 205
Cited by
Sorted by citations
Items 1,001–1,004 of 1,004
Lidow (1998) · doi:10.1002/(sici)1098-2396(199801)28:1
Young (2000) · doi:10.1002/1096-8628(20001009)96:5
Metadata
- Authors
- Koob, G. F.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Koob, George F.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 13
- Issue
- 5
- Pages
- 177-184
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2001865657
- Cited by
- 2,070
- References
- 73
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 12 · 2023: 16 · 2022: 17 · 2021: 28 · 2020: 30 · 2019: 28 · 2018: 46 · 2017: 42 · 2016: 43 · 2015: 37 · 2014: 58 · 2013: 53 · 2012: 53
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Pharmacological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA-08459)
- National Institute on Drug Abuse (DA04043, DA04398, R01DA004398, R01DA004043)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- drugs of abuse, brain reward system, dopamine, opioid system, GABA, nucleus accumbens, ventral tegmental area, ethanol reward, opioid reward, operant responding
- MeSH terms
- Animals, Brain, Humans, Reward, Illicit Drugs, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review